Compare Access Protocol (ACS) vs Injective (INJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Access Protocol vs Injective — how do they compare? Access Protocol trades at Rp2.21 (market cap Rp113,91M, Rp2,17M 24h volume), while Injective trades at Rp74,815 (market cap Rp7,84T, Rp671,51M 24h volume). The key difference: Injective is far larger — about 68826.3× Access Protocol's market cap, and Access Protocol's circulating supply is 51,6B ACS versus 100M INJ for Injective. Which is the better fit depends on your goals — on Pluang, investors hold Access Protocol for 16 Days and Injective for 37 Days on average.
| ACS | INJ | |
|---|---|---|
Market Cap | Rp113,91M | Rp7,84T |
Volume (24h) | Rp2,17M | Rp671,51M |
Circulating Supply | 51,6B ACS | 100M INJ |
Typical Hold Time | 16 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Access Protocol (ACS) is currently trading at Rp2.2343 with a market cap of Rp115.69 million, showing bearish technical signals with moving averages indicating strong selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp2 with similar support levels, suggesting consolidation. No major protocol updates or ecosystem developments have been reported recently, with limited trading activity observed.
Overall outlook remains cautious due to bearish technical indicators and low market cap. Key opportunities include potential accumulation at current levels, while major risks involve low liquidity, high volatility typical of small-cap cryptocurrencies, and limited network activity that could impact price stability.
INJ is currently trading at Rp81,847 with a market cap of Rp8.18 trillion, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp82,576 with support at Rp81,456. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks involve continued selling pressure and crypto market volatility. Investors should monitor network adoption metrics and exchange liquidity closely.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Access Protocol
Access Protocol provides a new method for digital media publications and content creators to monetize their work. Instead of traditional subscription payments, users stake the ACS token to gain access to premium digital content.
Read more on ACS →About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →
